ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
178 hedge funds and large institutions have $2.13B invested in Intra-Cellular Therapies Inc. in 2020 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 60 increasing their positions, 51 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% more funds holding
Funds holding: 176 → 178 (+2)
8% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 38
Holders
178
Holding in Top 10
3
Calls
$30.1M
Puts
$21.3M
Top Buyers
| 1 | +$29.4M | |
| 2 | +$19.9M | |
| 3 | +$14.6M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
+$13.2M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$11.5M |
Top Sellers
| 1 | -$14.3M | |
| 2 | -$12.8M | |
| 3 | -$11.8M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$10.7M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.96M |